Bone health care in women with breast cancer.
Stavroula A PaschouAreti AugouleaIrene LambrinoudakiPublished in: Hormones (Athens, Greece) (2019)
The aim of this article is to analyze and critically appraise the literature regarding optimal bone health care in women with breast cancer and, more specifically, to present (1) the causes of bone loss in breast cancer patients, (2) the appropriate screening for osteoporosis and fracture risk estimation, (3) optimal prevention and therapeutic strategies for osteoporosis and fractures, (4) the role of antiresorptive agents as adjuvant therapy for the prevention of bone metastases and increase of overall survival, and (5) current data on the possible use of menopausal hormone therapy (MHT) in these patients. The objective is to provide a sound pathophysiological background along with evidence-based and practical recommendations for physicians managing such women.
Keyphrases
- bone loss
- bone mineral density
- healthcare
- postmenopausal women
- end stage renal disease
- ejection fraction
- primary care
- early stage
- newly diagnosed
- chronic kidney disease
- systematic review
- peritoneal dialysis
- prognostic factors
- body composition
- stem cells
- soft tissue
- big data
- type diabetes
- clinical practice
- mesenchymal stem cells
- metabolic syndrome
- machine learning
- deep learning
- social media
- breast cancer risk
- pregnancy outcomes
- cell therapy
- patient reported